National Bank of Canada’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-410
Closed -$1.34K 2649
2024
Q2
$1.34K Buy
410
+10
+3% +$33 ﹤0.01% 2317
2024
Q1
$1.63K Sell
400
-6,600
-94% -$26.9K ﹤0.01% 2286
2023
Q4
$25.8K Sell
7,000
-5,000
-42% -$18.5K ﹤0.01% 1774
2023
Q3
$22.9K Buy
+12,000
New +$22.9K ﹤0.01% 1784
2023
Q1
Sell
-500
Closed -$5.04K 2592
2022
Q4
$5.04K Hold
500
﹤0.01% 2165
2022
Q3
$11K Sell
500
-500
-50% -$11K ﹤0.01% 1980
2022
Q2
$25K Buy
+1,000
New +$25K ﹤0.01% 1800